# Shopify Inc.: financial statements, quarterly SHOP · Nasdaq · CIK 1594805 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/shop.md) · [Financials](/companies/shop/financials.md) · [Filings](/companies/shop/filings.md) · [Insiders](/companies/shop/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shop/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,861](/filings/0001594805-25-000046.md) | [2,045](/filings/0001594805-25-000073.md) | [2,162](/filings/0001594805-25-000089.md) | [2,812 d](/filings/0001594805-26-000007.md) | [2,360](/filings/0001594805-26-000019.md) | [2,680](/filings/0001594805-26-000047.md) | [2,844](/filings/0001594805-25-000089.md) | [3,672 d](/filings/0001594805-26-000007.md) | [3,170](/filings/0001594805-26-000019.md) | [3,583](/filings/0001594805-26-000047.md) | | Cost of revenue | $m | [904](/filings/0001594805-25-000046.md) | [1,000](/filings/0001594805-25-000073.md) | [1,044](/filings/0001594805-25-000089.md) | [1,460 d](/filings/0001594805-26-000007.md) | [1,191](/filings/0001594805-26-000019.md) | [1,378](/filings/0001594805-26-000047.md) | [1,453](/filings/0001594805-25-000089.md) | [1,979 d](/filings/0001594805-26-000007.md) | [1,624](/filings/0001594805-26-000019.md) | [1,875](/filings/0001594805-26-000047.md) | | Gross profit | $m | [957](/filings/0001594805-25-000046.md) | [1,045](/filings/0001594805-25-000073.md) | [1,118](/filings/0001594805-25-000089.md) | [1,352 d](/filings/0001594805-26-000007.md) | [1,169](/filings/0001594805-26-000019.md) | [1,302](/filings/0001594805-26-000047.md) | [1,391](/filings/0001594805-25-000089.md) | [1,693 d](/filings/0001594805-26-000007.md) | [1,546](/filings/0001594805-26-000019.md) | [1,708](/filings/0001594805-26-000047.md) | | Research and development | $m | [335](/filings/0001594805-25-000046.md) | [349](/filings/0001594805-25-000073.md) | [332](/filings/0001594805-25-000089.md) | [351 d](/filings/0001594805-26-000007.md) | [377](/filings/0001594805-26-000019.md) | [394](/filings/0001594805-26-000047.md) | [375](/filings/0001594805-25-000089.md) | [390 d](/filings/0001594805-26-000007.md) | [437](/filings/0001594805-26-000019.md) | [445](/filings/0001594805-26-000047.md) | | Operating income | $m | [86.0](/filings/0001594805-25-000046.md) | [241](/filings/0001594805-25-000073.md) | [283](/filings/0001594805-25-000089.md) | [465 d](/filings/0001594805-26-000007.md) | [203](/filings/0001594805-26-000019.md) | [291](/filings/0001594805-26-000047.md) | [343](/filings/0001594805-25-000089.md) | [631 d](/filings/0001594805-26-000007.md) | [382](/filings/0001594805-26-000019.md) | [488](/filings/0001594805-26-000047.md) | | Income tax | $m | [17.0](/filings/0001594805-25-000046.md) | [32.0](/filings/0001594805-25-000073.md) | [32.0](/filings/0001594805-25-000089.md) | [128 d](/filings/0001594805-26-000007.md) | [(88.0)](/filings/0001594805-26-000019.md) | [173](/filings/0001594805-26-000047.md) | [44.0](/filings/0001594805-25-000089.md) | [149 d](/filings/0001594805-26-000007.md) | [(53.0)](/filings/0001594805-26-000019.md) | [273](/filings/0001594805-26-000047.md) | | Net income | $m | [(273)](/filings/0001594805-25-000046.md) | [171](/filings/0001594805-25-000073.md) | [828](/filings/0001594805-25-000089.md) | [1,293 d](/filings/0001594805-26-000007.md) | [(682)](/filings/0001594805-26-000019.md) | [906](/filings/0001594805-26-000047.md) | [264](/filings/0001594805-25-000089.md) | [743 d](/filings/0001594805-26-000007.md) | [(581)](/filings/0001594805-26-000019.md) | [1,502](/filings/0001594805-26-000047.md) | | Diluted EPS | $ per share | [(0.21)](/filings/0001594805-25-000046.md) | [0.13](/filings/0001594805-25-000073.md) | [0.64](/filings/0001594805-25-000089.md) | not reported | [(0.53)](/filings/0001594805-26-000019.md) | [0.69](/filings/0001594805-26-000047.md) | [0.20](/filings/0001594805-25-000089.md) | not reported | [(0.45)](/filings/0001594805-26-000019.md) | [1.16](/filings/0001594805-26-000047.md) | | Basic EPS | $ per share | [(0.21)](/filings/0001594805-25-000046.md) | [0.13](/filings/0001594805-25-000073.md) | [0.64](/filings/0001594805-25-000089.md) | not reported | [(0.53)](/filings/0001594805-26-000019.md) | [0.70](/filings/0001594805-26-000047.md) | [0.20](/filings/0001594805-25-000089.md) | not reported | [(0.45)](/filings/0001594805-26-000019.md) | [1.16](/filings/0001594805-26-000047.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.6](/filings/0001594805-24-000007.md) | [1.4](/filings/0001594805-25-000012.md) | not reported | not reported | not reported | [1.5](/filings/0001594805-26-000007.md) | [1.3](/filings/0001594805-25-000046.md) | [1.5](/filings/0001594805-25-000073.md) | [2.4](/filings/0001594805-25-000089.md) | [1.5](/filings/0001594805-26-000047.md) | [1.8](/filings/0001594805-26-000019.md) | [1.7](/filings/0001594805-26-000047.md) | | Current assets | $bn | [6.1](/filings/0001594805-24-000007.md) | [6.3](/filings/0001594805-25-000012.md) | not reported | not reported | not reported | [7.3](/filings/0001594805-26-000007.md) | [7.4](/filings/0001594805-25-000046.md) | [8.0](/filings/0001594805-25-000073.md) | [8.7](/filings/0001594805-25-000089.md) | [8.3](/filings/0001594805-26-000047.md) | [8.5](/filings/0001594805-26-000019.md) | [7.8](/filings/0001594805-26-000047.md) | | Total assets | $bn | [10.8](/filings/0001594805-24-000007.md) | [11.3](/filings/0001594805-25-000012.md) | not reported | not reported | not reported | [13.9](/filings/0001594805-26-000007.md) | [13.4](/filings/0001594805-25-000046.md) | [14.6](/filings/0001594805-25-000073.md) | [15.0](/filings/0001594805-25-000089.md) | [15.2](/filings/0001594805-26-000047.md) | [14.1](/filings/0001594805-26-000019.md) | [14.5](/filings/0001594805-26-000047.md) | | Current liabilities | $bn | [0.9](/filings/0001594805-24-000007.md) | [0.9](/filings/0001594805-25-000012.md) | not reported | not reported | not reported | [2.0](/filings/0001594805-26-000007.md) | [2.0](/filings/0001594805-25-000046.md) | [2.1](/filings/0001594805-25-000073.md) | [2.2](/filings/0001594805-25-000089.md) | [1.4](/filings/0001594805-26-000047.md) | [1.4](/filings/0001594805-26-000019.md) | [1.5](/filings/0001594805-26-000047.md) | | Shareholders' equity | $bn | [8.2](/filings/0001594805-26-000007.md) | [9.1](/filings/0001594805-26-000007.md) | [8.9](/filings/0001594805-25-000089.md) | [9.2](/filings/0001594805-25-000089.md) | [10.1](/filings/0001594805-25-000089.md) | [11.6](/filings/0001594805-26-000047.md) | [11.1](/filings/0001594805-26-000047.md) | [12.1](/filings/0001594805-26-000047.md) | [12.5](/filings/0001594805-25-000089.md) | [13.5](/filings/0001594805-26-000047.md) | [12.5](/filings/0001594805-26-000047.md) | [12.7](/filings/0001594805-26-000047.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [238](/filings/0001594805-25-000046.md) | [340](/filings/0001594805-25-000073.md) | [423](/filings/0001594805-25-000089.md) | [615 d](/filings/0001594805-26-000007.md) | [367](/filings/0001594805-26-000019.md) | [428](/filings/0001594805-26-000047.md) | [513](/filings/0001594805-25-000089.md) | [725 d](/filings/0001594805-26-000007.md) | [481](/filings/0001594805-26-000019.md) | [658](/filings/0001594805-26-000047.md) | | Capital expenditure | $m | [6.0](/filings/0001594805-25-000046.md) | [7.0](/filings/0001594805-25-000073.md) | [2.0](/filings/0001594805-25-000089.md) | [4.0 d](/filings/0001594805-26-000007.md) | [4.0](/filings/0001594805-26-000019.md) | [6.0](/filings/0001594805-26-000047.md) | [6.0](/filings/0001594805-25-000089.md) | [10.0 d](/filings/0001594805-26-000007.md) | [5.0](/filings/0001594805-26-000019.md) | [4.0](/filings/0001594805-26-000047.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001594805-26-000019.md) | [0.0](/filings/0001594805-26-000047.md) | not reported | not reported | [491](/filings/0001594805-26-000019.md) | [1,420](/filings/0001594805-26-000047.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [1,287](/filings/0001594805-25-000046.md) | [1,300](/filings/0001594805-25-000073.md) | [1,302](/filings/0001594805-25-000089.md) | [1,295](/filings/0001594805-26-000019.md) | [1,309](/filings/0001594805-26-000047.md) | [1,313](/filings/0001594805-25-000089.md) | [1,303](/filings/0001594805-26-000019.md) | [1,298](/filings/0001594805-26-000047.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.